Hybrid Event
20-22 May, 2025,
Steigenberger Wiltcher's, Brussels
20-22 May, 2025,
Steigenberger Wiltcher's, Brussels
Join Copenhagen Economics at EU Pharmaceutical Law Forum 2024
You're Invited to EU Pharma Law with an Exclusive 10% Off
We are excited to announce that Copenhagen Econmics will be participating at the EU Pharmaceutical Law Forum on 21-23 May 2024 at the Steigenberger Wiltcher's Hotel, Brussels. And, we are pleased to let you know that as a valued client of Copenhagen Econimcs, we have an exclusive 10% discount* for you. Your VIP discount code is: P24COPENHAGENECO
*T&C's Apply

Opening Remarks from Afternoon Chair
PANEL Market Access Challenges and Developments for Pharmaceutical Firms
- National developments for price transparency: recent decisions, legal issues and challenges
- Individual prices in tender decisions: to what extent do we need to make this transparent?
- Discounts and clawback schemes impacting reimbursement and turnover: German combination rebate, NHS VPAS scheme, schemes in France
- Latest trends & developments: HTA regulations - friend or foe?
Presented By:
PANEL Merger Control and Expanded Jurisdictional Reach Developments and Strategy
- Review of recent pharmaceutical merger control cases and authority approach
Article 22: the latest on Illumina/ Grail and implications for merger control strategy - Review of wider merger control cases: Pfizer/ Seagen and implications of Towercast judgments
- Comparison of EU developments to global trends in merger control
- How does merger control fit into overall regulatory scrutiny of the pharmaceutical industry?
- Practical commercial implications when planning for commercial deals